CONCORDBIO.BOCONCORDBIO.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+13.1%
5Y CAGR+14.1%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+13.1%/yr
Annual compound
5Y CAGR
+14.1%/yr
Consistent
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$6.02B+15.5%
2024$5.21B+0.6%
2023$5.18B+24.4%
2022$4.16B-3.2%
2021$4.30B+37.9%
2020$3.12B-